clarithromycin has been researched along with Dermatitis Medicamentosa in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (23.08) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Asano, A; Fukai, K; Sowa-Osako, J; Teramae, A; Tsuruta, D; Umekoji-Hayashi, A | 1 |
Cinotti, E; Fimiani, M; Rubegni, P; Tognetti, L | 1 |
Chen, SA; Chen, ZH; Jiang, ML; Luo, XQ; Qi, Z; Xing, QH; Xiong, H; Yang, FP; Yang, LL; Yang, Y; Zhang, LR; Zhu, HZ | 1 |
Badri, T; Daghfous, R; El Aidli, S; Kastalli, S; Lakhoua, G; Mebazaa, A; Sahnoun, R; Zaiem, A | 1 |
Ben Said, B; Bérard, F; Hacard, F; Huynh, VA; Lungoci, E; Nicolas, JF; Villani, A | 1 |
Akbay Harmandar, F; Çekin, AH; Çekin, Y; Şahintürk, Y; Uyar, S; Yolcular, BO | 1 |
Hero, I; Parr, DG; Stewart, DG; Stockley, RA | 1 |
Balatsouras, DG; Homsioglou, E; Kouskoukis, C; Rallis, E; Verros, C | 1 |
Alonso, JC; García, CM; Gonzalo, MJ; Melgosa, AC | 1 |
Drouet, M; Mauffret, N; Nicolie, B | 1 |
Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
Chieregato, C; Rosina, P; Schena, D | 1 |
Hamamoto, Y; Kinoshita, E; Muto, M; Ohmura, A | 1 |
2 trial(s) available for clarithromycin and Dermatitis Medicamentosa
Article | Year |
---|---|
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Amoxicillin; Anorexia; Anti-Bacterial Agents; Bifidobacterium animalis; Clarithromycin; Diarrhea; Dizziness; Drug Eruptions; Drug Resistance; Drug Therapy, Combination; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Nausea; Numbers Needed To Treat; Pantoprazole; Probiotics; Proton Pump Inhibitors; Symptom Assessment; Treatment Outcome | 2017 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
11 other study(ies) available for clarithromycin and Dermatitis Medicamentosa
Article | Year |
---|---|
Nonpigmenting and pigmenting fixed drug eruptions due to clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Eruptions; Female; Humans; Patch Tests | 2021 |
Bullous impetigo during interstitial pneumonitis.
Topics: Anti-Bacterial Agents; Blister; Child; Clarithromycin; Diagnosis, Differential; Drug Eruptions; Humans; Impetigo; Lung Diseases, Interstitial; Male; Penicillin Resistance; Pneumonia, Mycoplasma; Staphylococcus aureus | 2017 |
HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.
Topics: Adult; Aged; Alleles; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Eruptions; Female; Genetic Predisposition to Disease; Genotype; HLA-A Antigens; HLA-B Antigens; Humans; Male; Middle Aged; Molecular Docking Simulation; Risk Factors; Young Adult | 2018 |
Clarithromycin induced psoriasis in a 37-year old man.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Betamethasone; Clarithromycin; Drug Eruptions; Humans; Male; Psoriasis; Skin | 2014 |
[Fixed drug eruption to clarithromycin: The importance of challenge tests in diagnosis].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Eruptions; Humans; Male; Middle Aged; Patch Tests | 2016 |
Panniculitis secondary to extravasation of clarithromycin in a patient with alpha 1-antitrypsin deficiency (phenotype PiZ).
Topics: Adult; alpha 1-Antitrypsin Deficiency; Anti-Bacterial Agents; Clarithromycin; Drug Eruptions; Extravasation of Diagnostic and Therapeutic Materials; Female; Forearm; Humans; Panniculitis | 2003 |
Drug eruptions in children with ENT infections.
Topics: Acetaminophen; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Child; Child, Preschool; Clarithromycin; Clindamycin; Diagnosis, Differential; Drug Eruptions; Erythromycin; Female; Humans; Infant; Infections; Male; Otitis; Otorhinolaryngologic Diseases; Pharyngitis; Prospective Studies; Rhinitis; Risk Factors; Sinusitis; Stomatognathic Diseases; Tonsillitis | 2006 |
Fixed drug eruption on the tongue due to clarithromycin.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Diagnosis, Differential; Drug Eruptions; Female; Humans; Patch Tests; Tongue Diseases | 2005 |
[Unusual clinical form of amoxicillin allergy].
Topics: Amoxicillin; Clarithromycin; Drug Eruptions; Drug Therapy, Combination; Edema; Female; Humans; Methylprednisolone; Ofloxacin; Pruritus; Skin Tests; Stomatitis; Vulvovaginitis | 1996 |
Fixed drug eruption from clarithromycin.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Eruptions; Humans; Male; Middle Aged; Patch Tests; Skin Diseases; Tonsillitis | 1998 |
Fixed drug eruption due to clarithromycin.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Eruptions; Female; Humans | 2001 |